Pay in 4 interest-free payments of $5.74 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
And Zepbound (tirzepatide) is one of the latest additions in the GLP-1 landscape, one specifically approved by the Food and Drug Administration (FDA) for chronic weight management
Interactions May interact with anticoagulants Could affect absorption of certain medications Potential interactions with antifungal drugs May influence metabolism of certain medications Precaution Administer under medical supervision
Hims & Hers raised its full-year 2026 revenue guidance to a range of $2.8 billion to $3 billion, representing growth of 19% to 28% from 2025 levels, and updated adjusted EBITDA guidance to a range of $275 million to $350 million.
Clinical data for retatrutide shows injection site reactions in approximately 5 to 15 percent of participants, typically mild redness, itching, or small lumps that resolve within a day or two
This characteristic has allowed researchers to study its systemic biological effects across multiple experimental models
US$ 20.98
US$ 27.67
US$ 27.98
